Tag: business news

Indias Coffee Exports Hit USD 1.8 billion In FY25, Continues Four-Year Growth Streak

Posted on By Admin No Comments on Indias Coffee Exports Hit USD 1.8 billion In FY25, Continues Four-Year Growth Streak

New Delhi: India’s coffee exports have continued their strong upward trajectory, maintaining their billion-dollar streak for the fourth consecutive financial year, according to the Department of Commerce under the Ministry of Commerce and Industry. During the financial year 2024-25, India’s coffee exports reached USD 1.80 billion, marking a 40.2 per cent growth over the USD…

Read More “Indias Coffee Exports Hit USD 1.8 billion In FY25, Continues Four-Year Growth Streak” »

Business

‘Trump effect’ raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

Posted on By Admin No Comments on ‘Trump effect’ raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

Oils containing CBD (Cannabidiol). Geoffroy Van Der Hasselt | AFP | Getty Images Cannabis stocks could be poised for a rally after years of stagnation, fueled by investor optimism over the possibility for new federal rules for hemp-derived products and signals that President Donald Trump could take a more permissive stance on marijuana. Publicly traded…

Read More “‘Trump effect’ raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance” »

Health

Trump reaches deal with AstraZeneca to lower U.S. drug prices

Posted on By Admin No Comments on Trump reaches deal with AstraZeneca to lower U.S. drug prices

U.S. President Donald Trump participates in a bilateral meeting with Finland’s President Alexander Stubb (not pictured), in the Oval office at the White House in Washington, D.C., U.S., Oct. 9, 2025. Nathan Howard | Reuters The Trump administration and AstraZeneca announced Friday they have reached an agreement for the U.K.-based pharmaceutical giant to cut drug…

Read More “Trump reaches deal with AstraZeneca to lower U.S. drug prices” »

Health

CDC takes down more than a dozen webpages on sexual and gender identity, health equity

Posted on By Admin No Comments on CDC takes down more than a dozen webpages on sexual and gender identity, health equity

A sign for the CDC sits outside of their facility at the Centers for Disease Control and Prevention Roybal campus in Atlanta, Georgia, U.S., May 30, 2025. Megan Varner | Reuters More than a dozen pages on the Centers for Disease Control and Prevention website related to sexual and gender identity, health equity, and other…

Read More “CDC takes down more than a dozen webpages on sexual and gender identity, health equity” »

Health

Healthy Returns: New FDA rules affect copycat GLP-1s, and Apple adds health tools to its latest Watch

Posted on By Admin No Comments on Healthy Returns: New FDA rules affect copycat GLP-1s, and Apple adds health tools to its latest Watch

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009.  Jason Reed | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The Food…

Read More “Healthy Returns: New FDA rules affect copycat GLP-1s, and Apple adds health tools to its latest Watch” »

Health

Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors

Posted on By Admin No Comments on Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly‘s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street. In a key late-stage trial,…

Read More “Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors” »

Health

Omada Health beats on revenue in first earnings report since IPO

Posted on By Admin No Comments on Omada Health beats on revenue in first earnings report since IPO

The Omada Health logo is displayed on a smartphone screen. Sopa Images | Lightrocket | Getty Images Omada Health reported quarterly results for the first time since its initial public offering in June. Here’s how the company did based on average analysts’ estimates compiled by LSEG: Loss per share: 24 cents Revenue: $61 million vs. $55.2…

Read More “Omada Health beats on revenue in first earnings report since IPO” »

Health

Weight loss drugs could be a gamechanger for women with a common hormonal disorder

Posted on By Admin No Comments on Weight loss drugs could be a gamechanger for women with a common hormonal disorder

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images For well over a decade, Grace Hamilton, 27, experienced hair loss, heavy periods, infrequent menstrual cycles, mental health issues and difficulty losing weight without knowing why. It wasn’t until 2023 when she was diagnosed with…

Read More “Weight loss drugs could be a gamechanger for women with a common hormonal disorder” »

Health

Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals

Posted on By Admin No Comments on Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals

An aerial view of Valley Health Hampshire Memorial Hospital on June 17, 2025 in Romney, W.V. Ricky Carioti | The Washington Post | Getty Images President Donald Trump‘s “big beautiful bill” would make sweeping changes to U.S. health care, leaving millions of vulnerable Americans without health insurance and threatening the hospitals and centers that provide…

Read More “Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals” »

Health

Anne Wojcicki to buy back 23andMe and its data for $305 million

Posted on By Admin No Comments on Anne Wojcicki to buy back 23andMe and its data for $305 million

23andMe founder Anne Wojcicki speaks during a House Committee on Oversight and Government Reform hearing in Washington, D.C., on June 10, 2025. Andrew Harnik | Getty Images Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron Pharmaceuticals,…

Read More “Anne Wojcicki to buy back 23andMe and its data for $305 million” »

Health